| Ytd | -96.40% | |
| 1y | -99.35% |
| Open | 1.30 | Prev Close | 1.21 | Low | 1.18 | High | 1.40 | Mkt Cap | 5.82M |
| Vol | 36.16M | Avg Vol | 4.77M | EPS | -150.06 | P/E | N/A | Forward P/E | N/A |
| Beta | N/A | Short Ratio | 0.17 | Inst. Own | 18.20% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 1.85 | 200-d Avg | 50.67 | 1yr Est | 0.00 |
ELAB News
Three emerging biotechnology companies, Can-Fite (NYSE: CANF), NeOnc (NASDAQ: NTHI), and PMGC (NASDA
Yuva Biosciences' proprietary MitoNova™ AI platform identified small-molecule candidates that we
Yuva Biosciences' proprietary MitoNova™ AI platform identified small-molecule candidates that were b
PMGC Holdings Inc. (NASDAQ:ELAB) ("PMGC" or the "Company") today announced that its
PMGC's wholly owned operating companies positioned to serve the space economy include A&B Ae
NorthStrive Defense Tech LLC ("NorthStrive Defense Tech"), a wholly owned subsidiary of PMGC
Entry into a Material Definitive Agreement. (a) Term Sheet between NorthStrive Defense Tech LLC and
PMGC Holdings Inc. (NASDAQ:ELAB) ("PMGC", the "Company", "we" or "us"